The symposium will provide a comprehensive and clinically focused overview of bispecific therapies and their role in oncology. Topics will include review of bispecific agents, mechanism of action, and their clinical indications. Emphasis will be placed on administration, monitoring, and the management of side effects, including treatment-emergent complications. The education program will conclude with a focus on patient education and care coordination strategies that support optimal outcomes for patients receiving bispecific therapies.
This class is only open to UC Davis Health employees.
Location: Virtual
Date: Oct. 28, 2025
Time: 8 a.m. to 12:15 p.m.
Code: DAHS-NGNACBTCS25-BRN
Capacity: 100
Waiting list: Yes
Provider approved by the California Board of Registered Nursing, provider number CEP 26, for 4.0 contact hours.
Attendees will not receive C.E. credit if they are more than 20 minutes late; no partial credit can be awarded.
Registration Deposit $25
Register
Registrations are approved after your deposit is received. Registration deposit is returned upon completion of class.
Cancellation must be requested five days before the class date to receive a deposit refund.
Logan Bramble
Health Professions Education Specialist
Parking is available in parking structure 4, lots 12, 17, 22, 22 Auxiliary, 30, 30 Auxiliary, Broadway, EDD, and DOJ with either a B permit or daily permit. Daily permits are available for purchase with the ParkMobile app using zone number 42201 or at a parking kiosk. Please visit Parking and Transportation Services for more information.
Individuals needing special accommodations may call the Center for Professional Practice of Nursing at 916-734-9790.
UC Davis adheres to California's Proposition 209 which prohibits discrimination against or giving preferential treatment to any individual or group in public employment, public education, or public contracting on the basis of race, sex, color, ethnicity, or national origin.